Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and other common risk factors? In these cases, when are statin therapies not enough to provide optimal care? Dr. Brown also opines on the value of residual risk measurements.
Brought to you by:
